Cargando…
Acute myocardial infarction therapy using calycosin and tanshinone co-loaded; mitochondrion-targeted tetrapeptide and cyclic arginyl-glycyl-aspartic acid peptide co-modified lipid-polymer hybrid nano-system: preparation, characterization, and anti myocardial infarction activity assessment
Acute myocardial infarction (AMI) is one of the most common ischemic heart diseases. However, lack of sufficient drug concentration (in the ischemic heart) is the major factor of treatment failure. It is urgent for researchers to engineer novel drug delivery systems to enhance the targeted delivery...
Autores principales: | Yan, Jieke, Guo, Jing, Wang, Yuzhen, Xing, Xiaowei, Zhang, Xuguang, Zhang, Guanghao, Dong, Zhaoqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487946/ https://www.ncbi.nlm.nih.gov/pubmed/36047255 http://dx.doi.org/10.1080/10717544.2022.2118401 |
Ejemplares similares
-
THE EFFECT OF THE HYDROGEN ION CONCENTRATION ON THE RATE OF HYDROLYSIS OF GLYCYL GLYCINE, GLYCYL LEUCINE, GLYCYL ALANINE, GLYCYL ASPARAGINE, GLYCYL ASPARTIC ACID, AND BIURET BASE BY EREPSIN
por: Northrop, John H., et al.
Publicado: (1928) -
Tanshinone IIA attenuates heart failure via inhibiting oxidative stress in myocardial infarction rats
por: Chen, Ruijuan, et al.
Publicado: (2021) -
Tanshinone-IIA inhibits myocardial infarct via decreasing of the mitochondrial apoptotic signaling pathway in myocardiocytes
por: Fang, Yeqing, et al.
Publicado: (2021) -
Systemic Atherosclerotic Inflammation Following Acute Myocardial Infarction: Myocardial Infarction Begets Myocardial Infarction
por: Joshi, Nikhil V, et al.
Publicado: (2015) -
Myocardial Infarction
por: O'Toole, Laurence
Publicado: (1994)